Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. (2023)
Attributed to:
Systematic classification of phosphorylation sites for an integrative analysis of kinase signalling
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41392-022-01288-1
PubMed Identifier: 36843114
Publication URI: http://europepmc.org/abstract/MED/36843114
Type: Journal Article/Review
Volume: 8
Parent Publication: Signal transduction and targeted therapy
Issue: 1
ISSN: 2059-3635